-+ 0.00%
-+ 0.00%
-+ 0.00%

PERSPECTIVE THERAPEUTICS ANNOUNCES CLINICAL COLLABORATION AND SUPPLY AGREEMENT WITH MERCK TO EVALUATE [212PB]PSV359 IN COMBINATION WITH KEYTRUDA® (PEMBROLIZUMAB) IN FAP-Α POSITIVE SOLID TUMORS

Reuters·09/14/2026 10:16:00

Please log in to view news